Drugs / Timentin
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | TIMENTIN | — | 1985-04-01 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02158442 | Oct 2013 → Feb 2015 | diabetes mellitus, infectious disease | Osprey Medical, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Timentin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02158442 ↗ |
| Route | Intravenous | “intravenous Timentin” NCT02158442 ↗ |